Overview
Status
Suspended
Registry date
2018-06-21
Share capital
5,000.00 PLN
Registered address
ul. Gruszek I Jabłuszek 7, 05-502 Wólka Kozodawska, Poland
Financials
Revenue history (in k)
Filing timeliness
1 of 6 financial statements was filed late (for 2025, 54 days late).
- 202507/09/2026
- 202402/07/2025
- 202310/06/2024
- 202222/06/2023
- 202108/06/2022
- 202016/06/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 50.42kMedianUSD 443.18kAverageUSD 1.74m
Net profit
This companyUSD -13.32kMedianUSD 14.27kAverageUSD 128.63k
Operating costs
This companyUSD 57.43kMedianUSD 395.77kAverageUSD 1.56m
Assets
This companyUSD 35.93kMedianUSD 173.69kAverageUSD 1.02m
Industry
Authorized Representatives
Barbara Parda Głomska – Management Board Member
Grzegorz Jan Głomski – President of the Management Board
Manner of representation
Each member of the management board acting independently is authorised to submit declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Grzegorz Jan Głomskiage 63 | 50 | $675.31 | 50% |
Barbara Parda Głomskaage 62 | 50 | $675.31 | 50% |
Barbara Parda Głomska and Grzegorz Jan Głomski hold a combined 100% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jul 1, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Starosta Piaseczyński | |
| May 14, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Polski Fundusz Rozwoju S.A. |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Saska Medsp. z o.o. | $241,826.45 | saskamed.pl | ||
| Orlik Zdrowie i Edukacjasp. z o.o. | $257,578.35 | przychodnia-orlik.pl | ||
| Evolve Med Conceptsp. z o.o. | $159,159.36 | evolvemc.pl | ||
| Promindsp. z o.o. | $89,181.48 | promindclinic.pl | ||
| Luka Medicasp. z o.o. | $80,684.47 | lukamedica.pl | ||
| Onkomedicasp. z o.o. | $69,344.55 | onkomedica.pl | ||
| Cmradomsp. z o.o. | $62,882.97 | drkowalczewski.pl | ||
| Ibadanie.Plsp. z o.o. | $50,226.40 | ibadanie.pl | ||
| Oromedicasp. z o.o. | $25,191.68 | oromedica.pl | ||
| Biocells Medicalsp. z o.o. | $11,508.17 | biocellsmedical.com |
Change history
| Date | Event | |
|---|---|---|
| 2026-08-01 | Business suspended | |
| 2018-06-21 | Entered in the register |
FAQ
The main business activity of Beautydoc focuses on specialist medical practice activities.
The company was registered in the Polish National Court Register (KRS) on June 21, 2018.
The headquarters is located at: ul. Gruszek I Jabłuszek 7, 05-502 Wólka Kozodawska.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
The company reported a revenue of USD 42,996 in 2024, which is an increase of 35.5% compared to 2023.
No, the company recorded a net loss of USD 10,825 in 2024. For comparison, in 2023 the loss was USD 23,297, meaning the company reduced its loss by 55.9%.
The largest operating cost category falls under external services. This category amounted to USD 24,388 in 2024, representing 52% of all operating expenses.
Last updated: 2026-09-08